Valeant Steering Away From Aggressive Price Increases, Officials Say

Officials from Valeant Pharmaceuticals are telling a Senate committee that they are steering the company away from its practice of aggressively increasing drug prices.

from WSJ.com: US Business http://ift.tt/1TxpKyQ
via IFTTT